Parenteral nutrition decreases hepatic dihydropyrimidine dehydrogenase activity and modulates catabolism of 5-fluorouracil in rats

In Vivo. 2003 May-Jun;17(3):219-23.

Abstract

Background: Dihydropyrimidine dehydrogenase (DPD) is a rate-limiting enzyme in the catabolism of 5-fluorouracil (5-FU). The effect of parenteral nutrition (PN) on hepatic DPD activity and metabolism of 5-FU remains unknown.

Materials and methods: Rats were divided into two groups: a sham-operated oral feeding group (FED) and a PN group. After 7-day PN infusion, hepatic DPD activity, serum 5-FU levels and thymidylate synthase (TS) levels in the jejunum and tumor were measured.

Results: PN administration significantly decreased hepatic DPD activities. After infusion of 5-FU (40 mg/kg body), the serum 5-FU concentration and 5-fluoro-2'-deoxyuridine-5'-monophosphate (FdUMP)-bound TS levels in the jejunum were significantly higher in the PN group than the FED group (156.8 +/- 51.9 vs 100.5 +/- 51.9 ng/ml, p < 0.001 and 38.55 +/- 7.61 vs 22.89 +/- 4.46 pmol/g of tissue, p < 0.01, respectively). In Yoshida sarcoma-bearing rats, the FdUMP-bound TS level in the tumor did not differ significantly between the PN and FED rats.

Conclusion: PN decreases hepatic DPD activity, which may lead to increased toxicity of 5-FU.

MeSH terms

  • Animals
  • Biotransformation
  • Circadian Rhythm
  • Dihydrouracil Dehydrogenase (NADP) / metabolism*
  • Eating
  • Fluorouracil / blood
  • Fluorouracil / pharmacokinetics*
  • Jejunum / enzymology
  • Liver / metabolism*
  • Male
  • Parenteral Nutrition*
  • Rats
  • Rats, Inbred Strains
  • Thymidylate Synthase / metabolism

Substances

  • Dihydrouracil Dehydrogenase (NADP)
  • Thymidylate Synthase
  • Fluorouracil